| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide compositions which is useful in a therapeutic regimen for treating vascular abnormalities. <P>SOLUTION: The compositions contains a matrix forming component, a solid aggregate material, and a non-cyanoacrylate rheology modifying agent having an average molecular weight of at least 200,000. The matrix forming component contains at least an alkyl cyanoacrylate monomer, a stabilizer, and a plasticizer. The solid aggregate material contains at least a radiopacifier, and the composition solidifies upon contact with an ionic environment such as blood. <P>COPYRIGHT: (C)2009,JPO&INPIT |
